Unlock the new era of intelligence with Guidepoint Qsight, delivering unique, action-oriented insights into the MedTech market. Leverage the power of the industry’s most comprehensive dataset to make informed decisions seamlessly.
Unlock Deep Market Insights and Competitive Advantages in the MedTech Industry
Guidepoint Qsight empowers MedTech stakeholders by addressing the challenges of a rapidly evolving market with a unique blend of quantitative data and qualitative insights. The dynamic MedTech industry requires real-time, precise data to make informed decisions, which is why our solutions are vital.
Our MedTech Market Model, based on purchasing data from over 3,500 U.S. healthcare facilities, combined with our proprietary Practitioner Tracker—a survey-based longitudinal product—has revolutionized research capabilities. This comprehensive approach delivers deep market analysis, precise projections, and critical competitive insights. It is invaluable for any organization selling into or interested in tracking the MedTech space, empowering them to master industry complexities and maintain a competitive edge.
FAQs: How We Can Help MedTech Manufacturers
Qsight offers comprehensive market analysis, including highly accurate market size assessments, growth analysis, and detailed product performance tracking. This data helps MedTech companies understand market dynamics and strategically position their products.
Our competitive intelligence tools analyze data from over 3,500 healthcare facilities to provide insights into competitive positioning, market shares, and performance metrics, enabling MedTech companies to outmaneuver competitors strategically.
Qsight delivers in-depth insights into customer demographics, purchasing behaviors, and preferences. This information helps MedTech companies tailor their marketing strategies and product offerings to meet customer needs.
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
Our Newest Product Unleashed: Qsight Prospector
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
‘Tis the Season: Aesthetics Holiday Trends
With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.
Lightning Strikes the Peripheral Thrombectomy Market: Examining the Rise of Penumbra and the Impact of Innovative Devices
The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Rapid Ascend: Axonics Gains Ground in the SNM Market Amid F15 Launch and Next-Gen R20 System Arrival
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.